Robert W. Baird downgraded shares of CVS Health Corporation
(NYSE:CVS) from an outperform rating to a neutral rating in a report issued on
Thursday morning. The firm currently has $77.00 target price on the pharmacy
operator’s stock, down from their prior target price of $86.00.
Several other equities analysts also recently weighed in on
the stock. Vetr upgraded shares of CVS Health Corporation from a hold rating to
a buy rating and set a $86.87 target price for the company in a research note
on Monday, January 23rd. Guggenheim reiterated a buy rating and issued a $90.00
target price on shares of CVS Health Corporation in a research note on
Wednesday, December 28th. Credit Suisse Group reaffirmed a buy rating on shares
of CVS Health Corporation in a research note on Monday, December 19th.
Oppenheimer Holdings, Inc. set a $88.00 price objective on shares of CVS Health
Corporation and gave the company a buy rating in a research note on Sunday,
December 18th. Finally, Jefferies Group LLC assumed coverage on shares of CVS
Health Corporation in a research note on Monday, December 12th. They set a hold
rating and a $82.00 price objective for the company. Seven analysts have rated
the stock with a hold rating and twelve have given a buy rating to the stock.
CVS Health Corporation has an average rating of Buy and a consensus price
target of $100.27.
No comments:
Post a Comment